Medtech company PainChek (ASX: PCK) has secured its first disability services operator partnership with Nulsen Group commencing the use of PainChek’s world-first pain assessment smartphone app across five facilities. The 6-month trial is the first of its kind for PainChek with commercial terms falling within Australia’s National Disability Insurance Scheme (NDIS) and will enable both parties
Read MoreConfirming their commitment announced in April 2019, the Morrison Government has signed a $5 million grant to Australian medtech company PainChek (ASX: PCK) which will provide dementia patients with licences to utilise the facial recognition software for the purpose of assessing pain. Key to the software which has been clinically tested is its ability to
Read More